What one share of IDEAYA Biosciences holds
We are a precision medicine oncology company committed to the discovery, development, and commercialization of transformative therapies for cancer. Our approach integrates expertise in small-molecule drug discovery, structural biology and bioinformatics with robust internal capabilities in identifying and validating translational biomarkers to develop tailored, potentially first-in-class targeted therapies aligned to the genetic drivers of disease.
IDEAYA Biosciences’s numbers from its SEC filings, divided by its shares. Results cover the last 12 months to 2026-06-30; the balance sheet is as of 2026-06-30.
| Profit | −$1.96 |
|---|---|
| Capex (buildings and equipment) | $0.02 |
| Free cash flow | −$1.27 |
| Cash and investments | $12.90 |
| Book value | $12.44 |
Per share by fiscal year
| Year | Sales | Profit | Capex | Free cash | Dividends | Book value |
|---|---|---|---|---|---|---|
| 2017 | — | −$17.06 | $2.53 | −$20.11 | — | −$22.63 |
| 2018 | — | −$35.92 | $1.79 | −$30.67 | — | −$36.65 |
| 2019 | $0.00 | −$3.36 | $0.11 | −$3.25 | — | $4.94 |
| 2020 | $0.79 | −$1.40 | $0.02 | $2.22 | — | $6.71 |
| 2021 | $0.79 | −$1.41 | $0.07 | −$1.66 | — | $7.82 |
| 2022 | $1.23 | −$1.42 | $0.08 | −$2.19 | — | $7.25 |
| 2023 | $0.41 | −$1.96 | $0.04 | −$2.04 | — | $9.55 |
| 2024 | $0.09 | −$3.36 | $0.05 | −$3.08 | — | $12.24 |
| 2025 | $2.47 | −$1.28 | $0.03 | −$0.83 | — | $11.65 |
Common questions about IDEAYA Biosciences
How much does one share of IDEAYA Biosciences earn?
Over the last 12 months, IDEAYA Biosciences lost $1.96 for each share.
Does IDEAYA Biosciences pay a dividend?
IDEAYA Biosciences didn’t pay a dividend over the last 12 months, according to its SEC filings.
What is IDEAYA Biosciences’s book value per share?
IDEAYA Biosciences’s book value is $12.44 per share: what would be left for each share if it sold everything at the values on its books and paid every debt, as of June 30, 2026.
How much cash and debt does each share of IDEAYA Biosciences have?
Each share of IDEAYA Biosciences has $12.90 of cash and investments, as of June 30, 2026.
What is IDEAYA Biosciences’s free cash flow per share?
−$1.27 per share over the last 12 months. Free cash flow is the cash left over after spending on buildings and equipment.
Has IDEAYA Biosciences bought back shares?
IDEAYA Biosciences’s share count rose about 12625% from 2017 to 2025. That dilution means each share owns a smaller slice of the company.
From its SEC filings. For education only, not investment advice. New to these words? See the StockSlicer glossary.